These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2156347

  • 1. Increased fibrin/fibrinogen degradation products without increase of plasmin-alpha 2-plasmin inhibitor complex after hepatectomy for hepatocellular carcinoma.
    Takeda S, Katoh H, Takaki A, Okamoto K, Ohsato K.
    Thromb Res; 1990 Jan 15; 57(2):289-300. PubMed ID: 2156347
    [Abstract] [Full Text] [Related]

  • 2. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F, Hasegawa N, Asano K, Sayama K, Fujita H, Urano T, Aoki T, Ishizaka A, Kanazawa M, Kawashiro T.
    Kokyu To Junkan; 1992 Jul 15; 40(7):685-90. PubMed ID: 1387724
    [Abstract] [Full Text] [Related]

  • 3. Plasmin generation and fibrin(ogen)olysis following desmopressin infusion.
    Takahashi H, Tatewaki W, Wada K, Niwano H, Hanano M, Shibata A.
    Am J Hematol; 1991 Apr 15; 36(4):255-8. PubMed ID: 1826408
    [Abstract] [Full Text] [Related]

  • 4. The initiation of fibrinolysis in alpha 2-plasmin inhibitor deficient plasma. Role of fibrin.
    Ichinose A, Aoki N.
    Thromb Res; 1986 Mar 15; 41(6):847-54. PubMed ID: 2939589
    [Abstract] [Full Text] [Related]

  • 5. Basic Evaluation of the Newly Developed "Lias Auto P-FDP" Assay and the Influence of Plasmin-α2 Plasmin Inhibitor Complex Values on Discrepancy in the Comparison with "Lias Auto D-Dimer Neo" Assay.
    Kumano O, Ieko M, Komiyama Y, Naito S, Yoshida M, Takahashi N, Ohmura K, Hayasaki J, Hayakawa M.
    Clin Lab; 2018 Apr 01; 64(4):433-442. PubMed ID: 29739066
    [Abstract] [Full Text] [Related]

  • 6. Plasma alpha 2-plasmin inhibitor-plasmin complex and FDP-D-Dimer in fulminant hepatic failure.
    Tomiya T, Hayashi S, Ogata I, Fujiwara K.
    Thromb Res; 1989 Feb 01; 53(3):253-60. PubMed ID: 2524118
    [Abstract] [Full Text] [Related]

  • 7. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers.
    Kambayashi J, Sakon M, Yokota M, Shiba E, Kawasaki T, Mori T.
    Thromb Res; 1990 Oct 15; 60(2):157-67. PubMed ID: 2149215
    [Abstract] [Full Text] [Related]

  • 8. Activation of thrombosis and fibrinolysis following brain infarction.
    Kataoka S, Hirose G, Hori A, Shirakawa T, Saigan T.
    J Neurol Sci; 2000 Dec 01; 181(1-2):82-8. PubMed ID: 11099716
    [Abstract] [Full Text] [Related]

  • 9. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T, Muramatsu Y, Akashi S, Usui N.
    Nihon Jinzo Gakkai Shi; 1997 Mar 01; 39(2):144-9. PubMed ID: 9134831
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity?
    Marongiu F, Conti M, Mameli G, Sorano GG, Cossu E, Cirillo R, Balestrieri A.
    Thromb Res; 1990 Apr 15; 58(2):91-9. PubMed ID: 1693451
    [Abstract] [Full Text] [Related]

  • 14. Fibrinopeptide A and B beta 15-42 in liver cirrhosis.
    Marongiu F, Mameli G, Acca MR, Mulas G, Medda A, Tronci MB, Mamusa AM, Balestrieri A.
    Haemostasis; 1988 Apr 15; 18(2):126-8. PubMed ID: 2457543
    [Abstract] [Full Text] [Related]

  • 15. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG, Nguyen KT, Soundar E, Kostousov V, Bomgaars L, Moise A, Hui SK, Teruya J.
    Pediatr Crit Care Med; 2014 Jun 15; 15(5):e198-205. PubMed ID: 24614609
    [Abstract] [Full Text] [Related]

  • 16. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y, Watanabe K.
    Rinsho Byori; 1989 Mar 15; 37(3):248-55. PubMed ID: 2526263
    [No Abstract] [Full Text] [Related]

  • 17. [Correlations among FPB beta 15-42, PAC and D-dimer].
    Gando S, Tedo I.
    Rinsho Byori; 1991 Sep 15; 39(9):972-6. PubMed ID: 1834876
    [Abstract] [Full Text] [Related]

  • 18. alpha 2 Antiplasmin and disseminated intravascular coagulation in liver cirrhosis.
    Marongiu F, Mamusa AM, Mameli G, Mulas G, Solinas A, Demelia L, Contu L.
    Thromb Res; 1985 Jan 15; 37(2):287-94. PubMed ID: 3975873
    [Abstract] [Full Text] [Related]

  • 19. Enhanced coagulation-fibrinolysis in patients on regular hemodialysis treatment.
    Nakamura Y, Chida Y, Tomura S.
    Nephron; 1991 Jan 15; 58(2):201-4. PubMed ID: 1830934
    [Abstract] [Full Text] [Related]

  • 20. Fibrinolysis system in patients with bronchial asthma.
    Banach-Wawrzeńczyk E, Dziedziczko A, Rość D.
    Med Sci Monit; 2000 Jan 15; 6(1):103-7. PubMed ID: 11208294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.